TriasMD Introduces New Executive Team to Propel Growth Phase

TriasMD's New Executive Leadership Team to Drive Growth

TriasMD, a leader in ambulatory surgery, has officially announced a fresh executive leadership team that is set to guide the company into a promising new phase of growth. This strategic restructuring comes at a critical time for the organization, especially as it prepares to expand operations into Florida, marking its first foray into this market.

The new team comprises several seasoned professionals who bring a wealth of experience and expertise to their respective roles. At the forefront of this leadership change is Lee Levanduski, appointed as Chief Executive Officer (CEO). Levanduski has a robust background in clinical practice and healthcare management, boasting over 30 years of industry experience. His history of developing high-performing physician organizations is expected to play a pivotal role in shaping TriasMD's future trajectory.

Andrew Nice will assume the role of Chief Operating Officer (COO). Nice has demonstrated extensive operational expertise, particularly in scaling healthcare businesses. His appointment is seen as essential for enhancing operational efficiency and performance, which are crucial for the seamless execution of TriasMD's strategic vision.

In the financial domain, Mike Lembo has been named Chief Financial Officer (CFO). With significant experience in private equity-backed healthcare sectors, Lembo is set to oversee TriasMD’s financial strategy, ensuring that the company remains on a path of sustainable growth. His adept handling of financial matters during expansion periods will be invaluable as TriasMD opens its eighth Ambulatory Surgery Center (ASC).

TriasMD's Vice President of Marketing, Anthony Todaro, brings over 35 years of experience from both healthcare and consumer markets. His expertise will be instrumental in driving brand recognition and customer engagement strategies, vital components as the company launches into new regions.

The leadership team is rounded out by Rachel Jensen, who joins as Vice President of Supply Chain and Procurement, and Joey Dambroso as Controller. Jensen’s proven abilities in operational excellence across various high-growth sectors will support TriasMD’s need for a reliable supply chain strategy. Meanwhile, Dambroso’s experience in finance and accounting, gained through previous positions in some industry-leading firms, will further bolster the company’s financial oversight.

This comprehensive leadership team is expected to set a new standard for musculoskeletal care, particularly in the outpatient surgery landscape. As the healthcare industry shifts focus towards outpatient spine procedures—projected to grow at an annual rate of 15.7%—TriasMD positions itself to meet this demand effectively. This progress aligns with upcoming changes from the Centers for Medicare & Medicaid Services, which are set to accelerate the migration of complex procedures from hospitals to specialized outpatient facilities.

Robert S. Bray Jr., MD, FAANS and founder of TriasMD, expressed his confidence in the new leadership, stating that they are well-equipped to seize the opportunities presented by this shifting landscape. He emphasized the company's commitment to delivering patient-centered surgical care, which will be essential as they expand their unique model through the newly established centers of excellence.

In conclusion, TriasMD is on the verge of a significant transformation fueled by a strong executive team, strategic expansion plans, and an increasing focus on high-value healthcare delivery systems. The industry is watching closely, as the moves made by TriasMD in the near future could reshape outpatient surgical care as we know it. As discussions about the future of healthcare continue, TriasMD's leadership is set to play a critical role in this rapid evolution.

For more information about TriasMD and its expanding services, visit their official website at www.triasmd.com.